Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis have?
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis has 171 citations in the OpenAlex counts ScholarIQ stores.
When was Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis published?
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis has 2019 year in the ScholarIQ index.
What is the open-access status of Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis?
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis has green oa status in the ScholarIQ index.
What is the DOI of Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis?
The DOI for Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis is on the source record.
What is the PMID of Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis?
The PMID for Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis is on the source record.
What is the OpenAlex record for Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis?
The OpenAlex for Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis is on the source record.